HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
Eric C. Eichenwald, MD
Chief, Division of Neonatology
Dr. Eichenwald's research interests include clinical trials and quality improvement in neonatal-perinatal medicine. He has extensive experience in the conduct of multicenter clinical trials, having served as a site principal investigator for several funded, multicenter randomized trials of interventions aimed at improving outcomes of premature newborns.
Bio
Dr. Eichenwald's research interests include clinical trials, quality improvement in neonatal-perinatal medicine, epidemiology of infections in neonates, and apnea of prematurity.
He has extensive experience in conducting multicenter clinical trials, having served as a site principal investigator (PI) for several funded, multicenter randomized trials of therapies and interventions aimed at improving outcomes of premature newborns.
In addition, Dr. Eichenwald received extensive training in quality improvement methods and theory. He currently serves as PI for the University of Pennsylvania NIH Neonatal Research Network site, and co-PI for an RO1 grant on intermittent hypoxia and caffeine in preterm infants.
Education and Training
BA, Swarthmore College (History), 1980
MD, Harvard Medical School, 1984
Titles and Academic Titles
Chief, Division of Neonatology
Thomas Frederick McNair Scott Endowed Chair in Pediatrics
Attending Physician
Professor of Pediatrics
Professional Memberships
American Association of Pediatrics, 1998-
Society for Pediatric Research, 2001-
American Pediatric Society, 2008-
Publication Highlights
PubMed:
Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black DM, Ballard PL, Asselin JM, Truog WE, Merrill JD, Mammel MC, Steinhorn RH, Ryan RM, Durand DJ, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, Helderman J, Porta NF, Wadhawan R, Palermo L, Ballard RA. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 Apr; 183:19-25.e2. PMID: 28100402
Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn RH, Rogers EE, Ryan RM, Durand DJ, Asselin JM, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, O'Shea TM, Porta NF, Wadhawan R, Palermo L. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-9. PMID: 26500107
Merrill JD, Ballard PL, Courtney SE, Durand DJ, Hamvas A, Hibbs AM, Lu KW, Ryan RM, Reynolds AM, Spence K, Steinhorn RH, Truog WE, Eichenwald EC, Ballard RA. Pilot trial of late booster doses of surfactant for ventilated premature infants. J Perinatol. 2011 Sep; 31(9):599-606. PMID: 21311500
Di Fiore JM, Hibbs AM, Zadell AE, Merrill JD, Eichenwald EC, Puri AR, Mayock DE, Courtney SE, Ballard RA, Martin RJ. The effect of inhaled nitric oxide on pulmonary function in preterm infants. J Perinatol. 2007 Dec; 27(12):766-71. PMID: 17805339
Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE;. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006 Jul; 355(4):343-53. PMID: 16870913